SYRE FY 2020 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SYRESpyre Therapeutics, Inc.

$3B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$81M

Net Income

-$81M

EPS (Diluted)

$-37.89

Cash Flow

Operating Cash Flow

-$76M

Free Cash Flow

-$80M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$162M

Total Liabilities

$22M

Stockholders' Equity

$140M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$901,000	-80.2%
Operating Income	-$81M	-$80M	-1.4%
Net Income	-$81M	-$78M	-3.4%